MEDIPOST Co., Ltd.

Public

MEDIPOST Co., Ltd. is now publicly traded

The data on this page reflects MEDIPOST Co., Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Early Funding

Jan 9, 2026

Total Funding Raised

$140M

Company Overview

MEDIPOST Co., Ltd. is a biotechnology company that develops and commercializes allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven and degenerative diseases.

AI Layer

Non-AI

Keywords

stem cell therapycord blood bankingregenerative medicineallogeneic cell therapyosteoarthritis treatmentoff-the-shelf cell therapycontract development and manufacturing organizationCDMOknee cartilage repairumbilical cord bloodcell and gene therapy CDMObiotechnologyGMP manufacturinghUCB-MSCsnutritional supplements

MEDIPOST Co., Ltd. Comparables

Compare MEDIPOST Co., Ltd. with similar companies based on industry and business-model similarity.

MEDIPOST Co., Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

MEDIPOST Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Jan 9, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Antonio S J Lee

CEO Managing Director

Executive Team

MEDIPOST Co., Ltd. Investors

Notable investors and investment history

MEDIPOST Co., Ltd. investors
Investor	Rounds
Crescendo Equity Partners	Early Funding

View all Investors

MEDIPOST Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MEDIPOST Co., Ltd. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range38

Year Founded2000

Last FundingJan 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.